Notice ID: c0db19fbe5614411ae4d34a0b11a12abCombined Synopsis/Solicitation
T Cell Proliferation Assay
Archived on August 5, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−04:00
- Posted
- July 15, 2021
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Silver Spring, MD, 20993
- PSC
- AJ12: R&D- GENERAL SCIENCE/TECHNOLOGY: PHYSICAL SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- FDA-21-RFQ-1241954-2
- Notice ID
- c0db19fbe5614411ae4d34a0b11a12ab
Description
Please see attached solicitation for details. Update 7/15: Solicitation responses have been attached and the deadline for quotes has been extended until 3:00pm (Eastern) on Wednesday, July 21, 2021.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-21-RFQ-1241954-2- Combined Synopsis
- 2×Combined SynopsisCurrentJul 6, 2021
T Cell Proliferation Assay
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDA-21-RFQ-1241954-2
Archive Date
Aug 5, 2021
Office Address
Beltsville, MD, 20705